Latest Surgical oncology Stories
The Firm is investigating morcellator lawsuits on behalf of women who allegedly suffered the spread of uterine cancer due to power morcellation. New York, New
Ashley Brittain Landers of Schlichter, Bogard & Denton, LLP reports that the FDA has issued proposed orders to reclassify transvaginal mesh devices to the classification of high-risk.
Last month, the U.S.
The Firm is investigating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma or other cancers due to use of morcellation in laparoscopic hysterectomy
A new study has found that approximately 70 percent of women who have both breasts removed after having a breast cancer diagnosis in a single breast do it regardless of having a low risk of having cancer in the healthy breast.
Elite cancer care specialists in Turkey are providing the latest technology and the most innovative, affordable therapies to increase the chances of a cure.
Funds will expand commercialization of market-leading early-stage breast cancer treatment. (PRWEB) May 20, 2014 ALISO VIEJO, Calif:
The Firm is investigating morcellator lawsuits on behalf of women who experienced the spread of uterine sarcoma, leiomyoscarcoma, and other uterine cancers allegedly due to the use of a power
Panel discusses long-term effect on quality of life ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- A series of studies evaluating the outcomes, benefits, concerns and quality of life
The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.